Ultrasound, CT, and MRI are noninvasive imaging techniques used in the evaluation of PeVD. Catheter venography is another ...

Ovarian cancer is an incredibly deadly and common form of the disease, with approximately 7,500 new cases of ovarian cancer ...

Dr. Claire Thompson, a Consultant Gynaecological Oncologist at the Mater Misericordiae University Hospital and Rotunda ...

Glucagon-like peptide-1 (GLP-1) receptor agonists significantly enhance overall survival in patients with ovarian cancer, offering a promising adjunct to traditional treatments.

GET IT CHECKED!!! If the doctor pooh-poohs it, get it checked by a different doctor. Ultimately, what you do is up to you, but if you want to see your children's graduations, walk your little girl ...

Little is known about what causes ovarian cancer, and there is no way to detect it early yet. About 75% of the time when someone is diagnosed with ovarian cancer, it has already progressed to ...

Blood-based ctDNA testing missed KRAS mutations in 56% of low-grade serous ovarian cancer patients.

Novel drug combinations that improve survival outcomes, questions about treatment sequence, and encouraging results in chemo-resistant disease are highlights in ovarian cancer from ASCO 2025.

Consider ovarian cancer, a disease that often remains hidden until it has scattered itself across the abdomen. In 1993, researchers launched a major trial to test whether annual ultrasounds and ...

In this case report, corresponding author Naina Kumar from the All India Institute of Medical Sciences and team describe a rare ovarian tumor in a 70-year-old postmenopausal woman. The tumor was ...

A new case report was published in Volume 12 of Oncoscience on May 22, 2025, titled "A rare case: Pure Sertoli cell tumor uncovered in atrophic ovary during postmenopausal vault prolapse evaluation." ...

Learn how new diagnostic tools and treatment strategies are transforming Pelvic Inflammatory Disease care and improving reproductive health outcomes.